S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

Aerie Pharmaceuticals (AERI) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$15.25
$15.25
50-Day Range
$15.18
$15.25
52-Week Range
$4.81
$15.37
Volume
600 shs
Average Volume
974,748 shs
Market Capitalization
$753.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SourceHeadline
finance.yahoo.com logoGlobal Over the Counter (OTC) Drugs Market Size to Grow USD 265 Billion by 2032 | CAGR of 5.0%
finance.yahoo.com - November 28 at 8:46 AM
nypost.com logoAerie’s Black Friday Sale is here —Save 40% off sitewide for a limited time
nypost.com - November 25 at 12:41 PM
finance.yahoo.com logoNetarsudil for Fuchs Endothelial Corneal Dystrophy (FECD), 2019-2023 Emerging Drug Insights and Forecasts to 2032
finance.yahoo.com - November 23 at 12:49 PM
finance.yahoo.com logoGlobal Glaucoma Treatment Market Size To Grow USD 10.5 Billion by 2032 | CAGR of 5.0%
finance.yahoo.com - November 23 at 7:49 AM
finanznachrichten.de logoOpthea Limited: Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
finanznachrichten.de - October 27 at 7:43 AM
markets.businessinsider.com logoOpthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
markets.businessinsider.com - October 27 at 7:43 AM
finance.yahoo.com logoRetinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight
finance.yahoo.com - October 23 at 1:15 PM
uk.finance.yahoo.com logoRising Glaucoma Cases Forecast a Strong Optic Nerves Disorder Treatment Market
uk.finance.yahoo.com - September 25 at 8:34 AM
benzinga.com logoOptic Nerves Disorder Treatment Market Rises: North America Takes the Helm
benzinga.com - September 13 at 10:03 PM
time.com logoAerie Promo Codes
time.com - August 25 at 3:28 PM
uk.finance.yahoo.com logoAngina Pectoris Drugs Global Market Report 2023
uk.finance.yahoo.com - August 24 at 6:39 PM
uk.finance.yahoo.com logoOcular Hypertension Treatment Global Market Report 2023
uk.finance.yahoo.com - August 24 at 6:39 PM
msn.com logoAlcon (ALC) Gains From Robust Contact Lense Sales, Launches
msn.com - July 18 at 2:32 PM
finance.yahoo.com logoVillageMD Welcomes Richard Rubino as Chief Financial Officer
finance.yahoo.com - June 27 at 12:38 PM
marketwatch.com logoThe Glaucoma Therapeutics market's size, share, and revenue will be thoroughly examined, with an anticipated CAGR of 13% increase from 2023 to 2030.
marketwatch.com - June 22 at 7:09 PM
uk.finance.yahoo.com logoI-Mab Announces the Appointment of Raj Kannan as CEO
uk.finance.yahoo.com - June 22 at 8:59 AM
markets.businessinsider.com logoI-Mab Names Raj Kannan CEO - Quick Facts
markets.businessinsider.com - June 22 at 8:59 AM
uk.finance.yahoo.com logoOphthalmic Drugs Global Market Report 2023
uk.finance.yahoo.com - June 8 at 10:48 AM
msn.com logoAlcon (ALC) Vision Care Sales Robust, Margin Pressure Persists
msn.com - May 17 at 12:17 PM
marketwatch.com logoGlaucoma Therapeutics Market Size and Growth Analysis 2023-2031 by Absolute Reports with [121 Pages] in Pharmaceuticals Sector
marketwatch.com - May 17 at 12:17 PM
marketwatch.com logoOptic Nerves Disorder Treatment Market Size Fundamentals And Forecast Analysis 2023-2030
marketwatch.com - May 17 at 7:17 AM
marketwatch.com logoOphthalmology Therapeutics Market 2023: Global Opportunity Analysis by Revenue, Gross Margin, Market Share
marketwatch.com - May 16 at 9:16 PM
marketwatch.com logo2030 Vision: Ophthalmology Drugs Market Value to Hit New Heights
marketwatch.com - May 5 at 11:48 PM
marketwatch.com logoAnophthalmia and Microphthalmia Treatment Market Share, Size and Value Analysis with growing 5.3% CAGR during period 2023 to 2030
marketwatch.com - May 5 at 1:47 PM
marketwatch.com logoGlaucoma Therapeutics Market Trend Analysis, Future Demand, Updates (2023-2030)
marketwatch.com - May 4 at 5:44 PM
marketwatch.com logoRho Kinases Inhibitor Market 2023 Precise Outlook – Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis AG, AERIE PHARMACEUTICALS
marketwatch.com - May 4 at 12:44 PM
uk.news.yahoo.com logoMindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
uk.news.yahoo.com - May 2 at 9:29 AM
marketwatch.com logoGlaucoma Treatment Market Upcoming Trends, Size, Key Players, Revenue, Share, and Forecast 2023 to 2031
marketwatch.com - May 2 at 9:29 AM
marketwatch.com logoWave-Front Aberrometer Market Research 2023 Growth, Trends, Outlook and Future Scope Analysis 2031
marketwatch.com - April 28 at 10:41 PM
marketwatch.com logoGlaucoma and Dry Eye Diseases Market Research Analysis 2023-2031
marketwatch.com - April 27 at 4:07 PM
marketwatch.com logo2023 to 2030, Rho Associated Protein Kinase 2 Market Demand
marketwatch.com - April 27 at 11:07 AM
thestreet.com logoAerie Pharma Falls on Glaucoma Eye Drop Safety Concerns
thestreet.com - April 26 at 8:19 AM
finance.yahoo.com logoCAGR of 7.7% | Global Fuchs Endothelial Corneal Dystrophy Market Size To Grow USD 360 Billion By 2032
finance.yahoo.com - April 20 at 3:01 PM
finance.yahoo.com logoGlobal Glaucoma Therapeutics Market to Reach $7.2 Billion by 2030
finance.yahoo.com - April 14 at 10:37 AM
marketwatch.com logoOphthalmology Therapeutics Market Data Source, And Forecast 2030
marketwatch.com - April 13 at 6:57 PM
marketwatch.com logo2023 Rho Associated Protein Kinase 2 Market Share and Latest Growth Demand Status: Trends Analysis and Industry Expansion Strategies
marketwatch.com - April 7 at 8:05 PM
marketwatch.com logoRho Associated Protein Kinase 2 Market Growth Predictions and Forecast 2030
marketwatch.com - April 5 at 3:08 PM
marketwatch.com logoROCK2 Inhibitor Market 2023-2028: Future Updates
marketwatch.com - March 28 at 2:22 PM
marketwatch.com logoGlobal Nystagmus Market Size by Application (Hospitals & Clinics, Research Centers) Forecast from 2023 to 2028
marketwatch.com - March 27 at 1:02 PM
marketwatch.com logoRho-kinase Inhibitor Drugs Market Hitting New Highs by 2029 | Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis
marketwatch.com - March 27 at 1:02 PM
marketwatch.com logoRho Associated Protein Kinase 2 Market by 2031
marketwatch.com - March 27 at 8:02 AM
marketwatch.com logoOphthalmic Therapeutic Drugs Market Statistics [2023-2028]: Emerging Trends and Future Growth Scenario
marketwatch.com - March 21 at 10:02 AM
marketwatch.com logoOphthalmology Drugs Market Insights and Forecast to 2028
marketwatch.com - March 20 at 8:41 AM
finance.yahoo.com logoNanoscope Therapeutics Appoints Industry Veteran Vicente Anido Jr., Ph.D., as a Strategic Advisor
finance.yahoo.com - March 20 at 8:41 AM
marketwatch.com logoOphthalmic Products Market 2023 Segmented By Types, Applications and Top Key Players
marketwatch.com - March 17 at 9:34 AM
marketwatch.com logoGlaucoma Treatment Market [Latest Survey] 2023-2029: Estimated Industry Growth Across the World
marketwatch.com - March 15 at 10:53 PM
marketwatch.com logo2023-2029 Ophthalmology Therapeutics Market Share and Future Trends Analysis | Latest Growth Research Report
marketwatch.com - March 15 at 12:52 PM
insidermonkey.com logoAlcon Inc. (NYSE:ALC) Q4 2022 Earnings Call Transcript
insidermonkey.com - March 13 at 2:19 AM
msn.com logoAlcon (ALC) Unveils Expansive Vision Care Products at SECO 2023
msn.com - March 6 at 11:28 AM
marketwatch.com logoGlaucoma Therapeutics Market Size, Share, Outlook and Forecast to 2028
marketwatch.com - February 28 at 5:26 AM
Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.



AERI Media Mentions By Week

AERI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AERI
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

AERI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AERI Articles
This Week

0

1

AERI Articles
Average Week

Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AERI) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -